🇺🇸 FDA
Patent

US 6380371

Endoglycan: a novel protein having selectin ligand and chemokine presentation activity

expired A61KA61K38/00

Quick answer

US patent 6380371 (Endoglycan: a novel protein having selectin ligand and chemokine presentation activity) held by The Regents of the University of California expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00